Skip to main content
Erschienen in: Advances in Gerontology 1/2020

01.01.2020 | Kidney Cancer

Asymptomatic Kidney Tumors in Elderly Patients: Review of Treatment Approaches in Russia and Western Countries

verfasst von: Sh. Kh. Gantsev, A. A. Khmelevskiy, K. Sh. Gantsev, Y. N. Khrizman

Erschienen in: Advances in Gerontology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

This paper analyzes and evaluates the results of recent research on active observation strategies in North America and Europe. There are enough grounds for a more active implementation and use of this approach, which is permissible in a strictly selected category of patients, namely, in elderly patients. In Russia at the moment, the personalized approach to treatment is underdeveloped. Patients over 60–65 years old are a significant group of patients with kidney tumors. In the determination of the tactics of the care of these patients, it is important to understand that this contingent has a greater risk of death from comorbidities than the relatively low risk of death from kidney cancer. The improvement of modern diagnostic methods and the introduction of screening programs have led to a significant increase in the frequency of the detection of small kidney tumors in elderly patients. The results of studies comparing radical approaches to treatment and observation suggest the widespread adoption of a strategy for the active monitoring of asymptomatic kidney tumors in the elderly in Russian oncological practice.
Literatur
1.
Zurück zum Zitat Alekseev, B.Ya., Volkova, M.I., Kalpinskii, A.S., et al., Klinicheskie rekomendatsii po diagnostike i lecheniyu raka pochki (Clinical Recommendations for Diagnostics and Treatment of Bud Cancer), Moscow, 2014. Alekseev, B.Ya., Volkova, M.I., Kalpinskii, A.S., et al., Klinicheskie rekomendatsii po diagnostike i lecheniyu raka pochki (Clinical Recommendations for Diagnostics and Treatment of Bud Cancer), Moscow, 2014.
2.
Zurück zum Zitat Anisimov, V.N. and Belyaev, A.M., Onkogerontologiya: rukovodstvo dlya vrachei (Oncogerontology: Manual for Physicians), St. Petersburg, 2017. Anisimov, V.N. and Belyaev, A.M., Onkogerontologiya: rukovodstvo dlya vrachei (Oncogerontology: Manual for Physicians), St. Petersburg, 2017.
3.
Zurück zum Zitat Gantsev, Sh.Kh., Kzyrgalin, Sh.R., and Gantsev, K.Sh., Surgery in oncology: from advanced surgery to minimally invasive methods, Prakt. Onkol., 2017, vol. 18, no. 4, pp. 355–360. Gantsev, Sh.Kh., Kzyrgalin, Sh.R., and Gantsev, K.Sh., Surgery in oncology: from advanced surgery to minimally invasive methods, Prakt. Onkol., 2017, vol. 18, no. 4, pp. 355–360.
4.
Zurück zum Zitat Zlokachestvennye novoobrazovaniya v Rossii v 2017 g.: zabolevaemost’ i smertnost’ (Rate of Malignant Neoplasms in Russia in 2017: Morbidity and Mortality), Kaprin, A.D. et al., Eds., Moscow: Mosk. Nauchno-Issled. Onkol. Inst. im. P.A. Gertsena, 2018. Zlokachestvennye novoobrazovaniya v Rossii v 2017 g.: zabolevaemost’ i smertnost’ (Rate of Malignant Neoplasms in Russia in 2017: Morbidity and Mortality), Kaprin, A.D. et al., Eds., Moscow: Mosk. Nauchno-Issled. Onkol. Inst. im. P.A. Gertsena, 2018.
5.
Zurück zum Zitat Abouassaly, R., Lane, B.R., and Novick, A.C., Active surveillance of renal masses in elderly patients, J. Urol., 2008, vol. 180, pp. 505–508.CrossRef Abouassaly, R., Lane, B.R., and Novick, A.C., Active surveillance of renal masses in elderly patients, J. Urol., 2008, vol. 180, pp. 505–508.CrossRef
6.
Zurück zum Zitat Abou Youssif, T., Kassouf, W., Steinberg, J., et al., Active surveillance for selected patients with renal masses: updated results with long-term follow-up, Cancer, 2007, vol. 110, pp. 1010–1014.CrossRef Abou Youssif, T., Kassouf, W., Steinberg, J., et al., Active surveillance for selected patients with renal masses: updated results with long-term follow-up, Cancer, 2007, vol. 110, pp. 1010–1014.CrossRef
7.
Zurück zum Zitat Beisland, C., Hjelle, K.M., Reisaeter, L.A., et al., Observation should be considered as an alternative in management of renal masses in older and comorbid patients, Eur. Urol., 2009, vol. 55, pp. 1419–1429.CrossRef Beisland, C., Hjelle, K.M., Reisaeter, L.A., et al., Observation should be considered as an alternative in management of renal masses in older and comorbid patients, Eur. Urol., 2009, vol. 55, pp. 1419–1429.CrossRef
8.
Zurück zum Zitat Crispen, P.L., Wong, Y.N., Greenberg, R.E., et al., Predicting growth of solid renal masses under active surveillance, Urol. Oncol., 2008, vol. 26, pp. 555–559.CrossRef Crispen, P.L., Wong, Y.N., Greenberg, R.E., et al., Predicting growth of solid renal masses under active surveillance, Urol. Oncol., 2008, vol. 26, pp. 555–559.CrossRef
9.
Zurück zum Zitat Crispen, P.L., Viterbo, R., Boorjian, S.A., et al., Natural history, growth kinetics and outcomes of untreated clinically localized renal tumors under active surveillance, Cancer, 2009, vol. 115, pp. 2844–2852.CrossRef Crispen, P.L., Viterbo, R., Boorjian, S.A., et al., Natural history, growth kinetics and outcomes of untreated clinically localized renal tumors under active surveillance, Cancer, 2009, vol. 115, pp. 2844–2852.CrossRef
10.
Zurück zum Zitat Crispen, P.L., Viterbo, R., Fox, E.B., et al., Delayed intervention of sporadic renal masses undergoing active surveillance, Cancer, 2008, vol. 112, pp. 1051–1057.CrossRef Crispen, P.L., Viterbo, R., Fox, E.B., et al., Delayed intervention of sporadic renal masses undergoing active surveillance, Cancer, 2008, vol. 112, pp. 1051–1057.CrossRef
11.
Zurück zum Zitat Chawla S.N., Crispen, P.L., Hanlon, A.L., et al., The natural history of observed enhancing renal masses: meta-analysis and review of the world literature, J. Urol., 2006, vol. 175, pp. 425–431.CrossRef Chawla S.N., Crispen, P.L., Hanlon, A.L., et al., The natural history of observed enhancing renal masses: meta-analysis and review of the world literature, J. Urol., 2006, vol. 175, pp. 425–431.CrossRef
12.
Zurück zum Zitat Cancer research UK, 2017. https://www.cancerresearchuk.org. Cancer research UK, 2017. https://​www.​cancerresearchuk​.​org.​
13.
Zurück zum Zitat Ferlay, J., Shin, H.R., Bray, F., et al., Estimates of worldwide burden of cancer in 2008, J. Cancer, 2010, vol. 15, pp. 2893–2917. Ferlay, J., Shin, H.R., Bray, F., et al., Estimates of worldwide burden of cancer in 2008, J. Cancer, 2010, vol. 15, pp. 2893–2917.
14.
Zurück zum Zitat Ferlay, J., Parkin, D.M., and Steliarova-Foucher, E., Estimates of cancer incidence and mortality in Europe in 2008, Eur. J. Cancer, 2010, vol. 46, pp. 765–781.CrossRef Ferlay, J., Parkin, D.M., and Steliarova-Foucher, E., Estimates of cancer incidence and mortality in Europe in 2008, Eur. J. Cancer, 2010, vol. 46, pp. 765–781.CrossRef
15.
Zurück zum Zitat Hollingsworth, J.M., Miller, D.C., Daignault, S., et al., Rising incidence of small renal masses: a need to reassess treatment effect, J. Nat. Cancer Inst., 2006, vol. 98, no. 18, pp. 1331–1334.CrossRef Hollingsworth, J.M., Miller, D.C., Daignault, S., et al., Rising incidence of small renal masses: a need to reassess treatment effect, J. Nat. Cancer Inst., 2006, vol. 98, no. 18, pp. 1331–1334.CrossRef
16.
Zurück zum Zitat Jewett, M.A.S., Finelli, A., Link, I., et al., Active surveillance of small renal masses: a prospective muti-center Canadian Uro-Oncology Group trial, J. Urol., 2009, vol. 181, no. 4, p. 320.CrossRef Jewett, M.A.S., Finelli, A., Link, I., et al., Active surveillance of small renal masses: a prospective muti-center Canadian Uro-Oncology Group trial, J. Urol., 2009, vol. 181, no. 4, p. 320.CrossRef
17.
Zurück zum Zitat Jewett, M.A.S., Mattar, K., Basiuk, J., et al., Active surveillance of small renal masses: progression patterns of early stage kidney cancer, Eur. Urol., 2011, vol. 60, pp. 39–44.CrossRef Jewett, M.A.S., Mattar, K., Basiuk, J., et al., Active surveillance of small renal masses: progression patterns of early stage kidney cancer, Eur. Urol., 2011, vol. 60, pp. 39–44.CrossRef
18.
Zurück zum Zitat Jewett, M.A.S., Finelli, A., Link, I., et al., Active surveillance of small renal masses: a prospective muti-center Canadian Uro-Oncology Group trial, J. Urol., 2009, vol. 181, no. 4, p. 320.CrossRef Jewett, M.A.S., Finelli, A., Link, I., et al., Active surveillance of small renal masses: a prospective muti-center Canadian Uro-Oncology Group trial, J. Urol., 2009, vol. 181, no. 4, p. 320.CrossRef
19.
Zurück zum Zitat Jewett, M.A.S., The motion: surveillance is an option for renal cancer, Eur. Urol., 2006, vol. 50, pp. 1363–1366.CrossRef Jewett, M.A.S., The motion: surveillance is an option for renal cancer, Eur. Urol., 2006, vol. 50, pp. 1363–1366.CrossRef
20.
Zurück zum Zitat Jemal, A., Siegel, R., Xu, J., et al., Cancer statistics 2010, CA Cancer J. Clin., 2010, vol. 60, pp. 277–300.CrossRef Jemal, A., Siegel, R., Xu, J., et al., Cancer statistics 2010, CA Cancer J. Clin., 2010, vol. 60, pp. 277–300.CrossRef
21.
Zurück zum Zitat Jemal, A., Thun, M.J., Ries, L.A.G., et al., Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control, J. Nat. Cancer Inst., 2008, vol. 100, pp. 1672–1694.CrossRef Jemal, A., Thun, M.J., Ries, L.A.G., et al., Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control, J. Nat. Cancer Inst., 2008, vol. 100, pp. 1672–1694.CrossRef
22.
Zurück zum Zitat Karim-Kos, H.E., De Vries, E., Soerjomataram, I., et al., Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s, Eur. J. Cancer, 2008, vol. 44, pp. 1345–1389.CrossRef Karim-Kos, H.E., De Vries, E., Soerjomataram, I., et al., Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s, Eur. J. Cancer, 2008, vol. 44, pp. 1345–1389.CrossRef
23.
Zurück zum Zitat Lane, B.R., Abouassaly, R., Gao, T., et al., Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older, Cancer, 2010, vol. 116, pp. 3119–3126.CrossRef Lane, B.R., Abouassaly, R., Gao, T., et al., Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older, Cancer, 2010, vol. 116, pp. 3119–3126.CrossRef
24.
Zurück zum Zitat Luciani, L.G., Cestari, R., and Tallarigo, C., Incidental renal cell carcinoma—age and stage characterization and clinical implications: study of 1092 patients (1982–1997), Urology, 2000, vol. 56, pp. 58–62.CrossRef Luciani, L.G., Cestari, R., and Tallarigo, C., Incidental renal cell carcinoma—age and stage characterization and clinical implications: study of 1092 patients (1982–1997), Urology, 2000, vol. 56, pp. 58–62.CrossRef
25.
Zurück zum Zitat Ljungberg, B., Campbell, S.C., Choi, H.Y., et al., The epidemiology of renal cell carcinoma, Eur. Urol., 2011, vol. 60, no. 4, pp. 615–621.CrossRef Ljungberg, B., Campbell, S.C., Choi, H.Y., et al., The epidemiology of renal cell carcinoma, Eur. Urol., 2011, vol. 60, no. 4, pp. 615–621.CrossRef
26.
Zurück zum Zitat Levi, F., Ferlay, J., Galeone, C., et al., The changing pattern of kidney cancer incidence and mortality in Europe, BJU Int., 2008, vol. 101, no. 8, pp. 949–958.CrossRef Levi, F., Ferlay, J., Galeone, C., et al., The changing pattern of kidney cancer incidence and mortality in Europe, BJU Int., 2008, vol. 101, no. 8, pp. 949–958.CrossRef
27.
Zurück zum Zitat Mason, R.J., Abdolell, M., and Trottier, G., Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance, Eur. Urol., 2011, vol. 59, pp. 863–867.CrossRef Mason, R.J., Abdolell, M., and Trottier, G., Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance, Eur. Urol., 2011, vol. 59, pp. 863–867.CrossRef
28.
Zurück zum Zitat Proc. 4th Annual Genitourinary Cancers Symp., February 16, 2013, Orlando, 2013. Proc. 4th Annual Genitourinary Cancers Symp., February 16, 2013, Orlando, 2013.
29.
Zurück zum Zitat Rosales, J.C., Haramis, G., Moreno, J., et al., Active surveillance for renal cortical neoplasms, J. Urol., 2010, vol. 183, pp. 1698–1702.CrossRef Rosales, J.C., Haramis, G., Moreno, J., et al., Active surveillance for renal cortical neoplasms, J. Urol., 2010, vol. 183, pp. 1698–1702.CrossRef
30.
Zurück zum Zitat Stafford, H.S., Saltzstein, S.L., Shimasaki, S., et al., Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival, J. Urol., 2008, vol. 179, pp. 1704–1708.CrossRef Stafford, H.S., Saltzstein, S.L., Shimasaki, S., et al., Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival, J. Urol., 2008, vol. 179, pp. 1704–1708.CrossRef
31.
Zurück zum Zitat Siegel, R., Naishadham, D., and Jemal, A., Cancer statistics 2013, CA Cancer J. Clin., 2013, vol. 63, pp. 11–30.CrossRef Siegel, R., Naishadham, D., and Jemal, A., Cancer statistics 2013, CA Cancer J. Clin., 2013, vol. 63, pp. 11–30.CrossRef
32.
Zurück zum Zitat Yates, D.R. and Rouprét, M., Small renal mass and low-risk prostate cancer: any more for active surveillance?, Eur. Urol., 2011, vol. 60, pp. 45–47.CrossRef Yates, D.R. and Rouprét, M., Small renal mass and low-risk prostate cancer: any more for active surveillance?, Eur. Urol., 2011, vol. 60, pp. 45–47.CrossRef
Metadaten
Titel
Asymptomatic Kidney Tumors in Elderly Patients: Review of Treatment Approaches in Russia and Western Countries
verfasst von
Sh. Kh. Gantsev
A. A. Khmelevskiy
K. Sh. Gantsev
Y. N. Khrizman
Publikationsdatum
01.01.2020
Verlag
Pleiades Publishing
Erschienen in
Advances in Gerontology / Ausgabe 1/2020
Print ISSN: 2079-0570
Elektronische ISSN: 2079-0589
DOI
https://doi.org/10.1134/S2079057020010051

Weitere Artikel der Ausgabe 1/2020

Advances in Gerontology 1/2020 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Metformin rückt in den Hintergrund

24.04.2024 DGIM 2024 Kongressbericht

Es hat sich über Jahrzehnte klinisch bewährt. Doch wo harte Endpunkte zählen, ist Metformin als alleinige Erstlinientherapie nicht mehr zeitgemäß.

Myokarditis nach Infekt – Richtig schwierig wird es bei Profisportlern

24.04.2024 DGIM 2024 Kongressbericht

Unerkannte Herzmuskelentzündungen infolge einer Virusinfektion führen immer wieder dazu, dass junge, gesunde Menschen plötzlich beim Sport einen Herzstillstand bekommen. Gerade milde Herzbeteiligungen sind oft schwer zu diagnostizieren – speziell bei Leistungssportlern. 

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.